Polls on Doximity close soon. We hope you’ll consider nominating Montefiore Einstein Cardiology for the U.S. News & World Report Best Hospitals survey.
2021 Highlights
As challenging as 2021 was, Montefiore Einstein Cardiology made impressive strides in research, medical innovation and care. In addition to the many lifesaving procedures we performed, we broadened our footprint by establishing new outpatient and specialty clinics and contributing important scientific studies.
DATA & STATISTICS
Patients admitted and successfully treated for acute myocardial infarction, congestive heart failure and/or cardiac arrhythmias
Percutaneous coronary interventions
Pacemaker and defibrillator procedures
Heart transplants
Innovations and achievements
Dr. Leandro Slipczuk (Cardiac Imaging and Lipid Metabolism), in collaboration with Dr. Molly Fisher (Nephrology), Dr. Sasa Vukelic (Heart Failure and Transplant) and David Carruthers (Endocrinology), leads a program that provides treatment for hundreds of patients with complex disorders of lipid metabolism, uncontrolled diabetes or kidney disease, and who have or are at risk for cardiovascular disease.
We are the one and only destination in New York for bloodless heart transplantation and one of the most active programs attending patients in cardiogenic shock. Our heart transplant survival rates rival the best in the nation.
Together with the routine use of intracoronary imaging and the latest technologies to approach complex intracoronary lesions, such as intravascular lithotripsy, our management of one of the country’s busiest ST-elevation myocardial infarction (STEMI) programs allows our patients to undergo complete myocardial revascularization with excellent outcomes and noticeable improvement in their quality of life.
In 2021, we transmitted more than 100 live grand round lectures. Our faculty participated in over 50 national and international meetings and published more than 200 original articles in peer-reviewed journals.
Research Review
In 2021, we published over 200 scientific articles across a variety of topics.
Clinical Trials
In 2021, our department participated in over 30 active clinical trials. Through our management of one of the busiest STEMI programs in the US, along with our routine use of intracoronary imaging and the latest technologies—such as intravascular lithotripsy—to approach complex intracoronary lesions, our patients are able to undergo complete myocardial revascularization with excellent outcomes and noticeable improvement in their quality of life.
We expanded our footprint, opening Montefiore Einstein Advanced Care - Westchester and new outpatient clinics at White Plains Hospital, Wakefield Campus and Montefiore Heart Failure Center at Nyack Hospital. We are also finalizing plans for a comprehensive heart failure initiative, which will include specialty clinics for amyloid, sarcoid, hypertrophic cardiomyopathy and pulmonary hypertension, cardiac intensive care consultations at Nyack Hospital and a new catheterization laboratory. This initiative marks a major step toward solidifying Montefiore’s footprint and heart failure expertise in New York’s Hudson Valley region.
Polls on Doximity close soon. We hope you’ll consider nominating Montefiore Einstein Cardiology for the U.S. News & World Report Best Hospitals survey.
Delia Osborne
Assistant Director
dosborne@montefiore.org
Montefiore Einstein Center for Heart and Vascular Care
Montefiore.org
Einsteinmed.org
